VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒═══════════════════════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                                     │   Score │
╞═══════════════════════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ White Brazilian of European descent               │ White Brazilian of European descent               │     100 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Fulfillment of the Diagnostic and Statistical     │ Fulfillment of the Diagnostic and Statistical     │     100 │
│ Manual of Mental Disorders, Fourth Edition, (DSM- │ Manual of Mental Disorders, Fourth Edition, (DSM- │         │
│ IV) diagnostic criteria for ADHD                  │ IV) diagnostic criteria for ADHD                  │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Eligibility to immediate-release MPH (IR-MPH)     │ Eligibility to immediate-release MPH (IR-MPH)     │     100 │
│ treatment                                         │ treatment                                         │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Contraindication for IR-MPH use                   │ Contraindication for IR-MPH use                   │     100 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Current stimulant treatment                       │ Current stimulant treatment                       │     100 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Evidence of a clinically significant neurological │ Evidence of a clinically significant neurological │     100 │
│ disease that might affect cognition (e.g.,        │ disease that might affect cognition (e.g.,        │         │
│ delirium, dementia, epilepsy, head trauma, and    │ delirium, dementia, epilepsy, head trauma, and    │         │
│ multiple sclerosis)                               │ multiple sclerosis)                               │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Current or past history of psychosis              │ Current or past history of psychosis              │     100 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Estimated intelligence quotient score lower than  │ Estimated intelligence quotient score lower than  │     100 │
│ 70                                                │ 70                                                │         │
╘═══════════════════════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤═════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                       │   Score │
╞═══════════════════════════════════╪═════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ White Brazilian of European descent │      38 │
╘═══════════════════════════════════╧═════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 93.11111111111111
OverAll Ratio: 95.05555555555556
